In 2025, prominent Indian pharmaceutical companies like Sun Pharma, Zydus Lifesciences, and Syngene continued their US expansion through strategic acquisitions and investments, such as Sun Pharma’s purchase of Checkpoint Therapeutics for oncology assets, Zydus Lifesciences’ acquisition of a US manufacturing … Continue reading Acquisitions By Pharmaceutical Companies Of India In United States In 2025